Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor

Nature Structural Biology

Volumn 7, Issue 9, 2000, Pages 808-815

  Elkins, Patricia A ^a,b   Christinger, Hans W ^a   Sandowski, Yael ^c   Sakal, Edna ^c   Gertler, Arieh ^c   De Vos, Abraham M ^a   Kossiakoff, Anthony A ^a,d  

^a GENENTECH INC   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; ELECTROSTATICS; HUMAN GROWTH HORMONE; HUMANS; HYDROGEN BONDING; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PLACENTAL LACTOGEN; PROLACTIN; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, PROLACTIN; SEQUENCE ALIGNMENT; SHEEP; SOLVENTS; SUBSTRATE SPECIFICITY;

OVIS;

EID: 0033813066     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/79047     Document Type: Article

References (48)

1. DeVlaming, V. Actions of prolactin among the vertebrates. In Hormones and evolution (ed., Barrington, E.J.W.), 561-642 (Academic Press, New York; 1979).
2. Sinha, Y.N. Structural variants of prolactin: occurrence and physiological significance. Endocrine Rev. 16, 354-369 (1995).
3. Goffin, V., Shiverick, K.T., Kelly, P.A. & Martial, J.A. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocrine Rev. 17, 385-410 (1996).
4. Nicoll, C.S., Mayer, G.L & Russel, S.M. Structural features of prolactins and growth hormones that can be related to their biological properties. Endocrine Rev. 7, 169-203 (1986).
5. Gertler, A., Grosclaude, J., Strasburger, C.J., Nir, S. & Djiane, J. Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J. Biol. Chem. 271, 24482-24491 (1996).
6. De Vos, A.M., Ultsch, M. & Kossiakoff, A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312 (1992).
7. Kelly, P.A., et al. The growth hormone/prolactin receptor gene family. Oxford Surveys On Eukaryotic Genes 7, 29-50 (1991).
8. Schindler, C. & Darnell, J.E.J. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651 (1995).
9. Ihle, J.N., et al. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19, 222-227 (1994).
10. Bazan, J.F Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87, 6934-6938 (1990).
11. Cosman, D., et al. A new cytokine receptor superfamily. Trends Biochem. Sci. 15, 265-270 (1990).
12. Fuh, G., et al. Rational design of potent antagonists to the human growth hormone receptor. Science 256, 1677-1680 (1992).
13. Sandowski, Y., et al. Preparation and characterization of recombinant prolactin receptor extracellular domain from rat. Mol. Cell. Endocrinol. 115, 1-11 (1995).
14. Tchelet, A. Extracellular domain of prolactin receptor from bovine mammary gland: expression in Escherichia coli, purification and characterization of its interaction with lactogenic hormones. J. Endocrinol. 144, 393-403 (1995).
15. Sakal, E., et al. Large-scale preparation and characterization of recombinant ovine placental lactogen. J. Endocrinol. 152, 317-327 (1997).
16. Sakal, E., et al. Cloning, preparation, and characterization of biologically active recombinant caprine placental lactogen. J. Endocrinol. 159, 509-518 (1998).
17. Sakal, E., Elberg, G. & Gertler, A. Direct evidence that lactogenic hormones induce homodimerization of membrane-anchored prolactin receptor in intact Nb2-11C rat lymphoma cells. FEBS Lett. 410, 289-292 (1997).
18. Colosi, P., et al. Cloning and expression of ovine placental lactogen. Mol. Endocrinol. 3, 1462-1469 (1989).
19. Syed, R.S. et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516 (1998).
20. Livnah, O. et al. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å. Science 273, 464-471 (1996).
21. Kossiakoff, A.A. & De Vos, A.M. Structural basis for cytokine hormone-receptor recognition and receptor activation. Adv. Protein Chem. 52, 67-108 (1998).
22. Abdel-Meguid, S.S. et al. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc. Natl. acad. Sci. USA 84, 6434-6437 (1987).
23. Rhee, H.K. et al. Biological activity and immunological reactivity of human prolactin mutants. Endocrinology 136, 4990-49995 (1995).
24. Gertler, A., et al. Preparation, purification, and determination of the biological activities of 12 N terminus-truncated recombinant analogues of bovine placental lactogen. J. Biol. Chem. 267, 12655-12659 (1992).
25. Rosakis-Adcock, M. & Kelley, P.A. Identification of ligand binding determinants of the prolactin receptor. J. Biol. Chem. 267, 7428-7433 (1992).
26. Somers, W., Ultsch, M., De Vos, A.M. & Kossiakoff, A.A. The X-ray structure of the growth hormone-prolartin receptor complex. Nature 372, 478-481 (1994).
27. Kossiakoff, A.A. et al. Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci. 3, 1697-1705 (1994).
28. Wilson, I.A. & Jolliffe, L.K. The structure, organization, activation and plasticity of the erythropoietin receptor. Curr. Opin. Struct. Biol. 9, 696-704 (1999).
29. Cunningham, B.C. & Wells, J.A. Rational design of receptor-specific variants of human growth hormone. Proc. Natl. Acad. Sci. USA 88, 3407-3411 (1991).
30. Cunningham, B.C., Bass, S., Fuh, G. & Wells, J.A. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250, 1709-1712 (1990).
31. Clackson, T. & Wells, J.A. A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386 (1995).
32. Remy, I., Wilson, I.A. & Michnick, S.W. Erythropoietin receptor activation by ligand-induced conformation change science. Science 283, 990-993 (1999).
33. Livnah, O., et al. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nature Struct. Biol. 5, 993-1004 (1998).
34. Livnah, O. et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990 (1999).
35. Herman, A., Helman, D., Livnah, O. & Gertler, A. Ruminant placental lactogens act as antagonists to homologous growth hormone receptors and as agonists to human or rabbit growth hormone receptors. J. Biol. Chem. 274, 7631-7639 (1999).
36. Lebrun, J.J., Ali, S., Sofer, L., Ullrich, A. & Kelly, P.A. Prolactin-induced proliferation of Nb2 cells involves typrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem. 269, 14021-140266 (1994).
37. Argetsinger, L. et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244 (1993).
38. Pearce, K.H., Cunningham, B.C., Fuh, G., Teeri, T. & Wells, J.A. Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry 38, 81-89 (1999).
39. Christinger, H.W. et al. Crystallization of ovine placental lactogen in a 1:2 complex with the extracellular domain of the rat prolactin receptor. Acta Crystallogr. D 54, 1408-1411 (1998).
40. Collaborative Computational Project, Number 4. CCP4 Suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
41. Brünger, A.T. X-PLOR reference manual 3.0 edn (Molecular Simulations, Inc., Waltham, Massachusetts; 1992).
42. Huang, M. et al. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J. Mol. Biol. 275, 873-894 (1998).
43. Zhang, X.J. & Matthews, B.W. Enhancement of the method of molecular replacement by incorporation of known structural information. Acta Crystallogr. D 50, 675-686 (1994).
44. Inaka, K., Taniyama, Y., Kikuchi, M., Morikawa, K. & Matsushima, M. The crystal structure of a mutant human lysozyme C77/95A with increased secretion efficiency in yeast. J. Biol. Chem. 266, 12599-12603 (1991).
45. Brünger, A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475 (1992).
46. Read, R. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr. A 42, 140-149 (1986).
47. Lee, B. & Richards, F.M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55, 379-400 (1971).
48. Nicholls, A., Bharadwajj, R. & Honig, B. GRASP: graphical representation and analysis of surface properties. Biophys. J. 64, A166 (1993).